Literature DB >> 7541777

Genomic organization of the gene coding for the costimulatory human B-lymphocyte antigen B7-2 (CD86).

C L Jellis1, S S Wang, P Rennert, F Borriello, A H Sharpe, N R Green, G S Gray.   

Abstract

The generation of an antigen-specific T-cell response requires that the T lymphocyte receive two signals from the antigen presenting cell. The specificity of this response is provided by antigen presented to the T lymphocyte and involves stimulation of the T lymphocyte via the T-cell receptor (TCR)/CD3 complex. The second, or costimulatory signal, can be provided by ligation of the B-lymphocyte activation antigens B7-1 (CD80) and B7.2 (CD86) to TCR antigen CD28. The cDNAs for both CD80 and CD86 have been isolated and are predicted to encode type 1 membrane proteins of the immunoglobulin (Ig) superfamily. The predicted protein is composed of a signal peptide followed by two Ig-like extracellular domains, a transmembrane domain, and a cytoplasmic tail. Here we report that the genomic organization of CD86 reflects its functional structure, and is similar to that found for CD80. The gene is composed of eight exons which span more than 22 kilobases. The predicted protein functional domains of signal peptide, extracellular IgV- and IgC-like regions, and transmembrane domain coincide with the genomic structure. Two independent sequences had been reported for CD86 cDNA which differed in their 5'untranslated (UT) regions. We find CD86 exons 1 and 2 correspond to these alternate 5'UT sequences. Splicing of exon 1 or 2 with the signal peptide encoding exon 3 would produce mRNA transcripts complementary to the reported cDNA clones. Exons 4 and 5 correspond to IgV- and IgC-like extracellular domains, respectively. Exon 6 encodes the transmembrane region and beginning of the cytoplasmic tail. Exons 7 and 8 encode the remainder of the cytoplasmic tail and 3'UT sequences.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541777     DOI: 10.1007/bf00178582

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  28 in total

1.  CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones.

Authors:  F A Harding; J G McArthur; J A Gross; D H Raulet; J P Allison
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

2.  Antigen-specific and -nonspecific mitogenic signals in the activation of human T cell clones.

Authors:  E R Nisbet-Brown; J W Lee; R K Cheung; E W Gelfand
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

3.  Transplantation tolerance induced by CTLA4-Ig.

Authors:  T C Pearson; D Z Alexander; K J Winn; P S Linsley; R P Lowry; C P Larsen
Journal:  Transplantation       Date:  1994-06-27       Impact factor: 4.939

4.  Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.

Authors:  G J Freeman; J G Gribben; V A Boussiotis; J W Ng; V A Restivo; L A Lombard; G S Gray; L M Nadler
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

5.  Genomic organization and chromosomal location of the human gene encoding the B-lymphocyte activation antigen B7.

Authors:  A Selvakumar; B K Mohanraj; R L Eddy; T B Shows; P C White; B Dupont
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

6.  Murine B7 antigen provides an efficient costimulatory signal for activation of murine T lymphocytes via the T-cell receptor/CD3 complex.

Authors:  H Reiser; G J Freeman; Z Razi-Wolf; C D Gimmi; B Benacerraf; L M Nadler
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

7.  Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.

Authors:  D J Lenschow; Y Zeng; J R Thistlethwaite; A Montag; W Brady; M G Gibson; P S Linsley; J A Bluestone
Journal:  Science       Date:  1992-08-07       Impact factor: 47.728

8.  In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice.

Authors:  B R Blazar; P A Taylor; P S Linsley; D A Vallera
Journal:  Blood       Date:  1994-06-15       Impact factor: 22.113

9.  Characterization of the murine B7-1 genomic locus reveals an additional exon encoding an alternative cytoplasmic domain and a chromosomal location of chromosome 16, band B5.

Authors:  F Borriello; G J Freeman; S Edelhoff; C M Disteche; L M Nadler; A H Sharpe
Journal:  J Immunol       Date:  1994-12-01       Impact factor: 5.422

10.  Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.

Authors:  P S Linsley; W Brady; L Grosmaire; A Aruffo; N K Damle; J A Ledbetter
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  7 in total

1.  CD86 gene polymorphisms: no association with Type I diabetes among Finnish subjects.

Authors:  H Turpeinen; A-P Laine; S Nejentsev; M Sjöroos; J Ilonen; O Simell; R Veijola; M Knip; H K Akerblom; M Knip
Journal:  Diabetologia       Date:  2002-07       Impact factor: 10.122

2.  CD86 gene variants and susceptibility to pancreatic cancer.

Authors:  Honggang Xiang; Wei Zhao; Yanping Sun; Winnie Qian; Junjie Xing; Yujia Zhou; Jun Yao; Jian Xu; Yi Wang; Houshan Yao; Zhiqian Hu
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-21       Impact factor: 4.553

3.  Interleukin-1beta converting enzyme subfamily inhibitors prevent induction of CD86 molecules by butyrate through a CREB-dependent mechanism in HL60 cells.

Authors:  M Suzuki; F Shinohara; K Sato; T Taniguchi; H Takada; H Rikiishi
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

4.  A functional CD86 polymorphism associated with asthma and related allergic disorders.

Authors:  Thomas Juhl Corydon; Annette Haagerup; Thomas Gryesten Jensen; Helle Glud Binderup; Mikkel Steen Petersen; Keld Kaltoft; Jørgen Vestbo; Torben Arvid Kruse; Anders Dupont Børglum
Journal:  J Med Genet       Date:  2007-05-18       Impact factor: 6.318

5.  Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells.

Authors:  Ide Smets; Barnaby Fiddes; Josselyn E Garcia-Perez; Di He; Klara Mallants; Wenjia Liao; James Dooley; George Wang; Stephanie Humblet-Baron; Bénédicte Dubois; Alastair Compston; Joanne Jones; Alasdair Coles; Adrian Liston; Maria Ban; An Goris; Stephen Sawcer
Journal:  Brain       Date:  2018-03-01       Impact factor: 13.501

6.  Impact of Single-Nucleotide Polymorphisms of CTLA-4, CD80 and CD86 on the Effectiveness of Abatacept in Patients with Rheumatoid Arthritis.

Authors:  Noelia Marquez Pete; María Del Mar Maldonado Montoro; Cristina Pérez Ramírez; Almudena Sánchez Martín; Juan Enrique Martínez de la Plata; Fernando Martínez Martínez; Rafael Caliz Caliz; Abdelali Daddaoua; María Del Carmen Ramírez Tortosa; Alberto Jiménez Morales
Journal:  J Pers Med       Date:  2020-11-11

7.  Association of co-stimulatory human B-lymphocyte antigen B7-2 (CD86) gene polymorphism with colorectal cancer risk.

Authors:  Pedram Azimzadeh; Sara Romani; Hanieh Mirtalebi; Seyed Reza Fatemi; Shabnam Kazemian; Mahsa Khanyaghma; Seyed Reza Mohebbi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.